The American College of Cardiology (ACC) and American Heart Association (AHA) released a guideline for the therapy of blood cholesterol intended to reduce the risk of atherosclerotic cardiovascular disease (ASCVD) in an adult. One high risk group involves patients with clinical arteriosclerotic cardiovascular disease (ASCVD).
